Standard of Care and Treatment Strategies

Treating MPGN and C3G has entered a new era. For many years, doctors had to rely on broad, “one-size-fits-all” immune-suppressing drugs. Today, the focus has shifted toward targeted therapy—finding the specific biological driver of your kidney injury and neutralizing it ^[1][2].

Your treatment plan will typically be built in layers, starting with foundational kidney protection and adding more specific therapies based on your diagnosis.

The Foundation: Nephroprotective Care

Regardless of the cause of your MPGN or C3G, the first step for almost every patient is nephroprotective care. This isn’t just about treating the disease; it’s about making the environment in your kidneys as healthy as possible to slow down damage ^[3].

• RAAS Blockade: This involves using medications like ACE inhibitors (e.g., lisinopril) or ARBs (e.g., losartan). These drugs lower the pressure inside your kidneys’ filters and are the “gold standard” for reducing protein leakage ^[3][4]. However, they require individualized monitoring of blood pressure, creatinine, and potassium, and may be unsuitable in acute kidney injury, hyperkalemia, or pregnancy. Do not combine an ACE and an ARB.
• SGLT2 Inhibitors: These are a newer class of medications (like dapagliflozin or empagliflozin) that have shown significant benefits in many types of chronic kidney disease (CKD) by further protecting the filters and reducing the risk of kidney function decline ^[5][6]. SGLT2 inhibitors are not appropriate in every setting, such as some cases of acute illness, volume depletion, pregnancy, or high ketoacidosis risk. Never start or adjust these medications without your clinician’s guidance.
• Blood Pressure and Lipid Control: Keeping your blood pressure stable and your cholesterol in check is essential for long-term kidney survival ^[7][4].

Targeted Therapy: Finding and Treating the Cause

If your kidney injury is “secondary” (caused by something else), treating that underlying cause is the priority ^[1].

• Clone-Directed Therapy: If your MPGN is driven by a “monoclonal protein” (an error protein from your immune cells), standard kidney drugs aren’t enough. You may need therapy that targets the specific “clone” of cells making that protein. This approach has been shown to significantly improve kidney survival compared to traditional treatments ^[8][9].
• Infection or Autoimmune Treatment: If an infection like Hepatitis C or a disease like Lupus is the trigger, those must be managed directly to stop the kidney damage ^[10][1].

Modern Breakthroughs: Complement Inhibitors

For patients with primary C3G or primary IC-MPGN, the most exciting developments involve complement inhibitors. These drugs target the overactive “complement system” that is attacking your kidneys ^[1][11].

• Pegcetacoplan (VALIANT Trial): In a major study called VALIANT, this medication was tested in 124 patients with C3G or IC-MPGN. At 26 weeks, patients taking pegcetacoplan saw a 68.1% relative reduction in proteinuria compared to those on a placebo ^[12]. About 60% of patients achieved at least a 50% reduction in their protein levels ^[12].
• Iptacopan (APPEAR-C3G Trial): This is an oral medication that blocks a specific part of the complement system called “Factor B.” In the APPEAR-C3G study, it led to a 35.1% relative reduction in proteinuria at 6 months ^[13][11].

Note: Regulatory approvals and indications for these specific drugs vary by country. Proteinuria reduction is an important surrogate marker, but long-term data proving these treatments prevent kidney failure are still maturing.

Important Safety Note: Because these drugs “turn off” a part of your immune system, they increase the risk of certain infections, especially from encapsulated bacteria (like the ones that cause meningitis). Vaccination is ideally completed at least 2 weeks before treatment when feasible. Urgent treatment may proceed with clinician-directed antibacterial prophylaxis. Vaccination does not eliminate the risk of invasive infection; go to the emergency room immediately if you have symptoms like fever, severe headache, stiff neck, rash, or confusion ^[14][15].

The Role of Traditional Immunosuppression

Traditional drugs like mycophenolate mofetil (MMF) and corticosteroids (steroids) are still used, particularly for moderate to severe disease when secondary causes have been ruled out, though results can vary among individuals ^[16][17]. Today, they remain an important option, and complement blockade is not automatically first-line for every patient ^[1]. Your doctor will weigh the potential benefits of these drugs against their side effects, such as increased infection risk or bone thinning.